Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type b Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01453998
What this trial is testing

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Who this might be right for
Acellular PertussisHepatitis BHaemophilus Influenzae Type b+3 more
GlaxoSmithKline 657
Large-scale testing (Phase 3)Study completedNCT01580033
What this trial is testing

Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine

Who this might be right for
MeningitisInfluenza
Jiangsu Province Centers for Disease Control and Prevention 900
Large-scale testing (Phase 3)Study completedNCT00422292
What this trial is testing

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,664
Testing effectiveness (Phase 2)Study completedNCT01248884
What this trial is testing

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Who this might be right for
TetanusPoliomyelitisHepatitis B+3 more
GlaxoSmithKline 721
Large-scale testing (Phase 3)Study completedNCT00366366
What this trial is testing

To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines

Who this might be right for
Hepatitis B
GlaxoSmithKline 150
Not applicableUnknownNCT00932269
What this trial is testing

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Who this might be right for
DiphtheriaTetanusPertussis+6 more
Swedish Institute for Infectious Disease Control 5,400
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Large-scale testing (Phase 3)Study completedNCT00313911
What this trial is testing

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 2,133
Post-approval studies (Phase 4)Study completedNCT03530124
What this trial is testing

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Who this might be right for
ApneaApnea NeonatalPrematurity
Duke University 223
Testing effectiveness (Phase 2)Study completedNCT00289796
What this trial is testing

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 121
Large-scale testing (Phase 3)Study completedNCT02274285
What this trial is testing

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 424
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)Study completedNCT00317174
What this trial is testing

Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Who this might be right for
Haemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more
GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT00315055
What this trial is testing

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

Who this might be right for
Hepatitis BPolioDiphtheria+1 more
Sanofi Pasteur, a Sanofi Company 310
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Testing effectiveness (Phase 2)Study completedNCT00436007
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen

Who this might be right for
Malaria
GlaxoSmithKline 511
Testing effectiveness (Phase 2)Study completedNCT01106092
What this trial is testing

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Who this might be right for
Haemophilus Influenzae Type bTetanusHepatitis B+3 more
GlaxoSmithKline 312
Post-approval studies (Phase 4)Study completedNCT00158795
What this trial is testing

Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

Who this might be right for
Haemophilus Influenzae Type b Disease
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT01340937
What this trial is testing

V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 2,808
Testing effectiveness (Phase 2)Study completedNCT01457495
What this trial is testing

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more
GlaxoSmithKline 312
Next Page